SWOT Analysis for Solara Active Pharma Sciences Ltd. - Threats

Solara Active Pharma Sciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Stocks where Mutual Funds Increased Holdings in Past Month
Strong Annual EPS Growth
Bullish Harami (Bullish Reversal)
Good quarterly growth in the recent results	254.3% returns for Nifty 500 over 4.5 years
Effectively using its capital to generate profit - RoCE improving in last 2 years	-16.8% returns for Nifty 500 over 1.9 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Increasing Revenue every quarter for the past 3 quarters
Increasing profits every quarter for the past 3 quarters
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
FII / FPI or Institutions increasing their shareholding
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Companies with rising net profit margins - quarterly as well as TTM basis

MFs decreased their shareholding last quarter	190% returns for over 6.4 years
Promoter decreasing their shareholding
Declining Net Cash Flow : Companies not able to generate net cash
MACD crossed below zero line previous end of day
High promoter stock pledges
Highest increase in pledges by promoters

Broker price or reco upgrades in last month	-26.2% returns for Nifty 500 over 0.3 years
Companies with 10% increase in share price over three months, with rising net profit growth
Brokers upgraded recommendation or target price in the past three months	8.4% returns for Nifty 500 over 0.3 years
High Momentum Scores (Technical Scores greater than 50)	319.5% returns for Nifty 500 over 5.1 years
Highest Recovery from 52 Week Low

Stocks with Expensive Valuations according to the Trendlyne Valuation Score	177.2% returns for Nifty 500 over 4.5 years
Companies where promoters have increased their pledged stocks	28.5% returns for Nifty 500 over 2.9 years
Increasing Trend in Non-Core Income

Bullish or Bearish Candlestick Strength - Indices
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
Expensive Performers (DVM)	102.3% returns for over 5.4 years
Expensive Performers (DVM)	79.4% returns for over 5.4 years
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks	187.6% returns for Nifty 500 over 4.5 years
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks	181.7% returns for Nifty 500 over 4.5 years
RSI indicating price weakness
Top Losers
Broker price or reco upgrades in last month